SCTX Scribe Therapeutics Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

SCTX — —
Key stats
About
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836) · industry map
Exchange
XNAS
Market Cap
$0.4B
List Date
2026-07-24
CIK
0001853921
Next Earnings
2026-12-02
EPS Forecast
($0.42) (6 est.)
Headquarters
Alameda, CA
Homepage
https://www.scribetx.com

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan----
Feb----
Mar----
Apr----
May----
Jun----
Jul-10.02%-10.02%
Aug46.58%46.58%
Sep-36.53%-36.53%
Oct1.37%*1.37%
Nov----
Dec----
Total-15.14%-15.14%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $19.31
SMA 50: $25.21
SMA 200: —
Current: $17.38
EMA 12: $19.57
EMA 26: $21.14
MACD: -1.5740 | Signal: 0.1435
BEARISH
ADX (14): 21.81
WEAK TREND
+DI: 16.18
−DI: 28.69

Momentum Oscillators

RSI (14): 37.94
NEUTRAL
Stoch %K: 62.17
Stoch %D: 64.95
Williams %R: -54.74

Volume & Volatility

BB Upper: $23.08
BB Lower: $15.54
NEUTRAL
OBV: 1,306,530
Vol SMA 20: 475,041
Vol ROC: 25.79%
ATR: $2.81
True Range: $2.90
HV 20: 120.2%
HV 30: 130.8%
HV 60: 134.0%

Data Summary

Data Points: 63
Last Updated:
Date Range: 2026-07-24T00:00:00 – 2026-10-21T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

SCTX Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: -0.3325
Alpha: 4.77%
Correlation: -0.0277
R-Squared: 0.1%
Stock Volatility: 132.9%
Market Volatility: 11.1%

Analysis Details

Benchmark: SPY
Data Points: 63
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Beta & Alpha Over Time

SCTX Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

1 filers3,046 shares$56.06K value
# Filer Shares Value % of Total % of Float Period
1 TEMA ETFS LLC 3,046 $56.06K 100.00% — 2026-09-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

SCTX Insider Trading (Form 4)

Latest: 2026-07-29
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-29 ORBIMED ADVISORS LLC Director Mixed +2,697,650 $15.00 $30.00M EDGAR
2026-07-29 Carl L Gordon Director Mixed +1,348,825 $15.00 $15.00M EDGAR
2026-07-29 Jennifer A Doudna 10%+ Owner Conv (C) +12,511 — EDGAR
2026-07-29 Marc L Andreessen 10%+ Owner Mixed +18,496,350 $15.00 $30.00M EDGAR
2026-07-28 Brett Staahl 10%+ Owner Grant (A) +43,525 opt — EDGAR
2026-07-28 Avoro Ventures LLC Director Buy (P) +7,173,714 $15.16 $108.78M EDGAR
2026-07-27 Avoro Capital Advisors LLC Director Grant (A) +44,175 opt — EDGAR
2026-07-27 James Dean Watson Director Grant (A) +14,725 opt — EDGAR
2026-07-27 David Parrot Chief Financial Officer Buy (P) +2,666 $15.00 $40.0K EDGAR
2026-07-27 Joshua Bleharski Director Grant (A) +14,725 opt — EDGAR
2026-07-27 Svetlana Lucas Chief Business Officer Buy (P) +3,000 $15.00 $45.0K EDGAR
2026-07-27 Benjamin L. Oakes President, CEO Grant (A) +707,352 opt — EDGAR
2026-07-27 Carl L Gordon Director Grant (A) +14,725 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

SCTX Insider Holdings

7 insiders · @ $17.38
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Avoro Ventures LLC Director 3,080,983 $53.55M $108.78M 1 2026-07-28
2 Marc L Andreessen 10%+ Owner 2,051,742 $35.66M $30.00M 1 2026-07-29
3 Jennifer A Doudna 10%+ Owner 603,547 $10.49M $0 1 2026-07-29
4 ORBIMED ADVISORS LLC Director 348,825 $6.06M $30.00M 1 2026-07-29
5 Carl L Gordon Director 348,825 $6.06M $15.00M 2 2026-07-29
6 Svetlana Lucas Chief Business Officer 3,000 $52.1K $45.0K 1 2026-07-27
7 David Parrot Chief Financial Officer 1,333 $23.2K $40.0K 1 2026-07-27
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

SCTX Board & Officers

As of SEC filings through Jul 29, 2026

Directors 9

Officers 3

10% owners 11

Changes in the last 10 years (23)
Jul 28, 2026Behzad Aghazadeh first listed as a 10% owner in an SEC filing
Jul 28, 2026Avoro Capital Advisors LLC first listed as a 10% owner in an SEC filing
Jul 23, 2026Svetlana Lucas became Chief Business Officer
Jul 23, 2026Orbimed Advisors LLC became a director
Jul 23, 2026OrbiMed Capital GP VIII LLC became a director
Jul 23, 2026Marc L Andreessen became a 10% owner
Jul 23, 2026Joshua Bleharski became a director
Jul 23, 2026Jennifer A Doudna became a 10% owner
Jul 23, 2026James Dean Watson became a director
Jul 23, 2026ELI LILLY & Co became a 10% owner
Jul 23, 2026David Parrot became Chief Financial Officer
Jul 23, 2026Carl L Gordon became a director
Jul 23, 2026Brett Staahl became a 10% owner
Jul 23, 2026Benjamin L. Oakes became a director
Jul 23, 2026Benjamin L. Oakes became President, CEO
Jul 23, 2026Benjamin A Horowitz became a 10% owner
Jul 23, 2026Behzad Aghazadeh became a director
Jul 23, 2026Avoro Ventures LLC became a director
Jul 23, 2026Avoro Capital Advisors LLC became a director
Jul 23, 2026AH Equity Partners Bio III, L.L.C. became a 10% owner
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
17 ETFs hold SCTX
17 shown · $15.99M total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $5.3M — 2026-09-30
2 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.01% $4.9M $75.1B 2026-10-20
3 VXF Vanguard Extended Market ETF Vanguard 0.00% $1.9M — 2026-09-30
4 VTWO Vanguard Russell 2000 ETF Vanguard 0.01% $1.0M — 2026-09-30
5 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.01% $1.0M $13.6B 2026-10-20
6 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.01% $850,463 $13.7B 2026-10-20
7 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.05% $579,700 $1.2B 2026-10-20
8 VTWG Vanguard Russell 2000 Growth ETF Vanguard 0.01% $118,767 — 2026-09-30
9 RSSL Global X Russell 2000 ETF Global X 0.01% $90,092 — 2026-10-21
10 VTWV Vanguard Russell 2000 Value ETF Vanguard 0.00% $64,786 — 2026-09-30
11 VTHR Vanguard Russell 3000 ETF Vanguard 0.00% $15,129 — 2026-09-30
12 ITWO ProShares Russell 2000 High Income ETF ProShares 0.01% $10,808 — 2026-10-21
13 URTY ProShares UltraPro Russell2000 ProShares 0.00% $8,415 — 2026-10-21
14 UWM ProShares Ultra Russell2000 ProShares 0.00% $5,443 — 2026-10-21
15 HDG ProShares Hedge Replication ETF ProShares 0.00% $232 — 2026-10-21
16 RB ProShares Russell 2000 Dynamic Buffer ETF ProShares 0.01% $77 — 2026-10-21
17 ARKG ARK Genomic Revolution ETF ARK Invest 0.91% — — 2026-10-21
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.